Medizinische Universität Graz - Research portal

Navigation/Search

• Researchers.
• Institutions.
  • Address and mission.
  • Equipment/Knowhow.
  • Staff.
  • Projects.
  • Publications.
  • Advised theses.
  • Project partners.
  • Sponsors.
• Projects.
• Publications.
• Partners.
• Sponsors.
• Equipment.
• Knowhow.
• Fields of Research.

Department of Internal Medicine

Division of Endocrinology and Diabetology

Project partners

Abteilung für Neurologie, LKH Klagenfurt, Klagenfurt, Austria

Mutation distribution and identification of novel genes in hereditary neuropathies
• Project type: EN: Forschungsförderung.
• Project Leader: Auer-Grumbach Michaela
• MUG Research Units: Department of Internal Medicine, Joint Facilities ; Division of Endocrinology and Diabetology ;
• Funded by: FWF, Fonds zur Förderung der Wissenschaftlichen Forschung, Wien, Austria
• Programme: Einzelprojekt
• Duration: 01.11.2006-31.03.2011
   .

Abteilung für Neurologie, Oberwart, Oberwart, Austria

Mutation distribution and identification of novel genes in hereditary neuropathies
• Project type: EN: Forschungsförderung.
• Project Leader: Auer-Grumbach Michaela
• MUG Research Units: Department of Internal Medicine, Joint Facilities ; Division of Endocrinology and Diabetology ;
• Funded by: FWF, Fonds zur Förderung der Wissenschaftlichen Forschung, Wien, Austria
• Programme: Einzelprojekt
• Duration: 01.11.2006-31.03.2011
   .

Austrian peripheral neuropathy study group, Austria

Mutation distribution and identification of novel genes in hereditary neuropathies
• Project type: EN: Forschungsförderung.
• Project Leader: Auer-Grumbach Michaela
• MUG Research Units: Department of Internal Medicine, Joint Facilities ; Division of Endocrinology and Diabetology ;
• Funded by: FWF, Fonds zur Förderung der Wissenschaftlichen Forschung, Wien, Austria
• Programme: Einzelprojekt
• Duration: 01.11.2006-31.03.2011
   .

Bionanonet Forschungsgesellschaft mbH, Austria

Single-Port Insulin Infusion for Improved Diabetes Management
• Project type: EN: Forschungsförderung.
• Project Leader: Treiber Gerlies
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.11.2012-31.10.2017
   .

DICE Danube Integrated Circuit Engineering GmbH&Co KG, Austria

Nanoelectronics for Mobile Ambient Assisted Living (AAL) Systems - Technology Platform for AAL Applications - MAS
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium Österreichische Forschungsförderungsgesellschaft mbH (FFG/mit peer review), Sensengasse 1, 1090 Wien, Austria
• Programme: EU (FP-7)
• Duration: 01.04.2010-30.09.2013
   .

Infineon Technologies Austria AG, Austria

Nanoelectronics for Mobile Ambient Assisted Living (AAL) Systems - Technology Platform for AAL Applications - MAS
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium Österreichische Forschungsförderungsgesellschaft mbH (FFG/mit peer review), Sensengasse 1, 1090 Wien, Austria
• Programme: EU (FP-7)
• Duration: 01.04.2010-30.09.2013
   .

Institut für Maschinelles Sehen/Technische Universität Graz , Inffeldgasse 16/II, 8010 Graz, Austria

COMET - Common Mechanisms in Autoimmune Diseases
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: CBmed Center for Biomarker Research in Medicine ; Department of Neurology ; Division of Endocrinology and Diabetology ; Division of Rheumatology and Immunology ;
• Funded by: JDRF - Juvenile Diabetes Research Foundation, 200 Vesey Street, New York, United States (USA)
• Duration: 01.01.2021-31.12.2023
   .

COMET - Common Mechanisms in Autoimmune Diseases
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: CBmed Center for Biomarker Research in Medicine ; Department of Neurology ; Division of Endocrinology and Diabetology ; Division of Rheumatology and Immunology ;
• Funded by: Lupus Research Alliance - LRA, 275 Madison Avenue, New York, United States (USA)
• Duration: 01.01.2021-31.12.2023
   .

Institut für Molekulare Biowissenschaften / Universität Graz, Heinrichstrasse 31A, 8010 Graz, Austria

Inflammatory Mechanisms in Diabetes Uncovered by Tissue Imaging and Machine Learning
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Gottfried Schatz Research Center (for Cell Signaling, Metabolism and Aging) ;
• Funded by: BioTechMed-Graz, Mozartgasse 12/II, 8010 Graz, Austria
• Duration: 01.01.2020-31.12.2023
   .

Joanneum Research Forschungsgesellschaft mbH, Steyrergasse 17, 8010 Graz, Austria

NR4A1-P53 AXIS IN THE IMMUNE EVASION OF AGGRESSIVE LYMPHOMAS
• Project type: EN: Forschungsförderung.
• Project Leader: Deutsch Alexander
• MUG Research Units: Division of Haematology ; Gottfried Schatz Research Center (for Cell Signaling, Metabolism and Aging) ;
• Funded by: FWF, Fonds zur Förderung der Wissenschaftlichen Forschung, Wien, Austria
• Programme: Forschungsgruppen
• Duration: 03.06.2024-02.06.2029
   .

Clinical application for metabolic profiling
• Project type: EN: Forschungsförderung.
• Project Leader: Schaupp Lukas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.12.2010-30.04.2015
   .

Remote Assessibility to Diabetes Management and Therapy in Operational healthcare Networks - REACTION
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.03.2010-28.02.2014
   .

Single-Port Insulin Infusion for Improved Diabetes Management
• Project type: EN: Forschungsförderung.
• Project Leader: Treiber Gerlies
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.11.2012-31.10.2017
   .

Medizinische Universität Innsbruck (MUI), Innsbruck, Austria

COMET - Common Mechanisms in Autoimmune Diseases
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: CBmed Center for Biomarker Research in Medicine ; Department of Neurology ; Division of Endocrinology and Diabetology ; Division of Rheumatology and Immunology ;
• Funded by: JDRF - Juvenile Diabetes Research Foundation, 200 Vesey Street, New York, United States (USA)
• Duration: 01.01.2021-31.12.2023
   .

COMET - Common Mechanisms in Autoimmune Diseases
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: CBmed Center for Biomarker Research in Medicine ; Department of Neurology ; Division of Endocrinology and Diabetology ; Division of Rheumatology and Immunology ;
• Funded by: Lupus Research Alliance - LRA, 275 Madison Avenue, New York, United States (USA)
• Duration: 01.01.2021-31.12.2023
   .

Siemens Aktiengesellschaft Österreich, Austria

Nanoelectronics for Mobile Ambient Assisted Living (AAL) Systems - Technology Platform for AAL Applications - MAS
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium Österreichische Forschungsförderungsgesellschaft mbH (FFG/mit peer review), Sensengasse 1, 1090 Wien, Austria
• Programme: EU (FP-7)
• Duration: 01.04.2010-30.09.2013
   .

Technische Universität Graz, Graz, Austria

Nanoelectronics for Mobile Ambient Assisted Living (AAL) Systems - Technology Platform for AAL Applications - MAS
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium Österreichische Forschungsförderungsgesellschaft mbH (FFG/mit peer review), Sensengasse 1, 1090 Wien, Austria
• Programme: EU (FP-7)
• Duration: 01.04.2010-30.09.2013
   .

Technische Universität Graz, Infeldgasse 16, 8010 Graz, Austria

Inflammatory Mechanisms in Diabetes Uncovered by Tissue Imaging and Machine Learning
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Gottfried Schatz Research Center (for Cell Signaling, Metabolism and Aging) ;
• Funded by: BioTechMed-Graz, Mozartgasse 12/II, 8010 Graz, Austria
• Duration: 01.01.2020-31.12.2023
   .

Technische Universität Wien, Karlsplatz 13, 1040 Wien, Austria

Nanoelectronics for Mobile Ambient Assisted Living (AAL) Systems - Technology Platform for AAL Applications - MAS
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium Österreichische Forschungsförderungsgesellschaft mbH (FFG/mit peer review), Sensengasse 1, 1090 Wien, Austria
• Programme: EU (FP-7)
• Duration: 01.04.2010-30.09.2013
   .

4a engineering GmbH, Industriepark 1, 8772 Traboch, Austria

AP@home
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.02.2010-31.10.2014
   .

FUNDICO BVBA, OOSTKAMP, Belgium

PoC in-office device for identifying individuals at high risk of Osteoporosis and osteoporotic fracture
• Project type: EN: Forschungsförderung.
• Project Leader: Dimai Hans Peter
• MUG Research Units: Biobank Graz ; Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.10.2017-31.03.2022
   .

Universiteit Gent, Belgium

PoC in-office device for identifying individuals at high risk of Osteoporosis and osteoporotic fracture
• Project type: EN: Forschungsförderung.
• Project Leader: Dimai Hans Peter
• MUG Research Units: Biobank Graz ; Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.10.2017-31.03.2022
   .

University Libre de Bruxelles, Brüssel, Belgium

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

Vrije Universiteit Brussel, Pleinlaan 2, 1050 Brüssel, Belgium

Remote Assessibility to Diabetes Management and Therapy in Operational healthcare Networks - REACTION
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.03.2010-28.02.2014
   .

Brno University of Technology, Czech Republic

Nanoelectronics for Mobile Ambient Assisted Living (AAL) Systems - Technology Platform for AAL Applications - MAS
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium Österreichische Forschungsförderungsgesellschaft mbH (FFG/mit peer review), Sensengasse 1, 1090 Wien, Austria
• Programme: EU (FP-7)
• Duration: 01.04.2010-30.09.2013
   .

BVT Technologies, Czech Republic

Clinical application for metabolic profiling
• Project type: EN: Forschungsförderung.
• Project Leader: Schaupp Lukas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.12.2010-30.04.2015
   .

Czech Technical University in Prague, Czech Republic

Nanoelectronics for Mobile Ambient Assisted Living (AAL) Systems - Technology Platform for AAL Applications - MAS
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium Österreichische Forschungsförderungsgesellschaft mbH (FFG/mit peer review), Sensengasse 1, 1090 Wien, Austria
• Programme: EU (FP-7)
• Duration: 01.04.2010-30.09.2013
   .

Institut Mikroelektronickych Aplikaci SRO, Czech Republic

Nanoelectronics for Mobile Ambient Assisted Living (AAL) Systems - Technology Platform for AAL Applications - MAS
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium Österreichische Forschungsförderungsgesellschaft mbH (FFG/mit peer review), Sensengasse 1, 1090 Wien, Austria
• Programme: EU (FP-7)
• Duration: 01.04.2010-30.09.2013
   .

Aarhus Universitetshospital, Denmark

Food-based solutions for Optimal vitamin D Nutrition and Health through the life cycle (ODIN)
• Project type: EN: Forschungsförderung.
• Project Leader: Pilz Stefan
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.11.2013-31.10.2017
   .

Danmarks Tekniske Universitet, Denmark

Food-based solutions for Optimal vitamin D Nutrition and Health through the life cycle (ODIN)
• Project type: EN: Forschungsförderung.
• Project Leader: Pilz Stefan
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.11.2013-31.10.2017
   .

Delta Dansk Elektronik Lys and Akustik, Venlighedsvej 4, DK-2970 Horsholm, Denmark

Remote Assessibility to Diabetes Management and Therapy in Operational healthcare Networks - REACTION
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.03.2010-28.02.2014
   .

In-Jet ApS, Jeppe Aakjærs Vej 15, 3460 Birkerod, Denmark

Remote Assessibility to Diabetes Management and Therapy in Operational healthcare Networks - REACTION
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.03.2010-28.02.2014
   .

Kobenhavns Universitet, Denmark

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

Food-based solutions for Optimal vitamin D Nutrition and Health through the life cycle (ODIN)
• Project type: EN: Forschungsförderung.
• Project Leader: Pilz Stefan
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.11.2013-31.10.2017
   .

NovoNordisk, Denmark

A Portable bihormonal Closed Loop for Diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Regittnig Werner
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.09.2012-31.05.2016
   .

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

Region Hovedstaden, Kongens Vaenge 2, 3400 Hillerod, Denmark

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

Helsingin Yliopisto, Helsinki, Finland

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

Food-based solutions for Optimal vitamin D Nutrition and Health through the life cycle (ODIN)
• Project type: EN: Forschungsförderung.
• Project Leader: Pilz Stefan
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.11.2013-31.10.2017
   .

Turku University, Turku, Finland

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

University of Oulu, Finland

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

AKIRA technologies sarl, France

Single-Port Insulin Infusion for Improved Diabetes Management
• Project type: EN: Forschungsförderung.
• Project Leader: Treiber Gerlies
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.11.2012-31.10.2017
   .

CHRU MONTPELLIER, 191 Avenue du Doyen Gaston Giraud, 34295 Montpellier, France

AP@home
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.02.2010-31.10.2014
   .

Institut de la Sante de la Recherche Medicale (INSERM), France

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

Oberthur Technologies, France

Nanoelectronics for Mobile Ambient Assisted Living (AAL) Systems - Technology Platform for AAL Applications - MAS
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium Österreichische Forschungsförderungsgesellschaft mbH (FFG/mit peer review), Sensengasse 1, 1090 Wien, Austria
• Programme: EU (FP-7)
• Duration: 01.04.2010-30.09.2013
   .

Rescoll, France

Single-Port Insulin Infusion for Improved Diabetes Management
• Project type: EN: Forschungsförderung.
• Project Leader: Treiber Gerlies
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.11.2012-31.10.2017
   .

Sanofi-Aventis Recherche & Development, Chilly, France

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

Sarl Endocells, Paris, France

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

Bayer Technology Services GmbH, Leverkusen, Germany

Remote Assessibility to Diabetes Management and Therapy in Operational healthcare Networks - REACTION
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.03.2010-28.02.2014
   .

Charite-Universitätsmedizin Berlin, Berlin, Germany

Nanoelectronics for Mobile Ambient Assisted Living (AAL) Systems - Technology Platform for AAL Applications - MAS
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium Österreichische Forschungsförderungsgesellschaft mbH (FFG/mit peer review), Sensengasse 1, 1090 Wien, Austria
• Programme: EU (FP-7)
• Duration: 01.04.2010-30.09.2013
   .

Corscience GmbH & CO KG, Germany

Nanoelectronics for Mobile Ambient Assisted Living (AAL) Systems - Technology Platform for AAL Applications - MAS
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium Österreichische Forschungsförderungsgesellschaft mbH (FFG/mit peer review), Sensengasse 1, 1090 Wien, Austria
• Programme: EU (FP-7)
• Duration: 01.04.2010-30.09.2013
   .

Fraunhofer Gesellschaft zur Förderung der angewandten Forschung e.V., Germany

Nanoelectronics for Mobile Ambient Assisted Living (AAL) Systems - Technology Platform for AAL Applications - MAS
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium Österreichische Forschungsförderungsgesellschaft mbH (FFG/mit peer review), Sensengasse 1, 1090 Wien, Austria
• Programme: EU (FP-7)
• Duration: 01.04.2010-30.09.2013
   .

PoC in-office device for identifying individuals at high risk of Osteoporosis and osteoporotic fracture
• Project type: EN: Forschungsförderung.
• Project Leader: Dimai Hans Peter
• MUG Research Units: Biobank Graz ; Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.10.2017-31.03.2022
   .

Remote Assessibility to Diabetes Management and Therapy in Operational healthcare Networks - REACTION
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.03.2010-28.02.2014
   .

Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany

Nanoelectronics for Mobile Ambient Assisted Living (AAL) Systems - Technology Platform for AAL Applications - MAS
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium Österreichische Forschungsförderungsgesellschaft mbH (FFG/mit peer review), Sensengasse 1, 1090 Wien, Austria
• Programme: EU (FP-7)
• Duration: 01.04.2010-30.09.2013
   .

Gottfried Wilhelm Leibniz Universität Hannover, Germany

Nanoelectronics for Mobile Ambient Assisted Living (AAL) Systems - Technology Platform for AAL Applications - MAS
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium Österreichische Forschungsförderungsgesellschaft mbH (FFG/mit peer review), Sensengasse 1, 1090 Wien, Austria
• Programme: EU (FP-7)
• Duration: 01.04.2010-30.09.2013
   .

Hannoversche Kinderheilanstalt, Hannover, Germany

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

Helmholtz Zentrum München-Deutsches Forschungszentrum für Gesundheit und Umwelt, Landstraße 1, 85764 Neuherberg, Germany

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

Infineon Technologies AG*IFAG, Germany

Nanoelectronics for Mobile Ambient Assisted Living (AAL) Systems - Technology Platform for AAL Applications - MAS
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium Österreichische Forschungsförderungsgesellschaft mbH (FFG/mit peer review), Sensengasse 1, 1090 Wien, Austria
• Programme: EU (FP-7)
• Duration: 01.04.2010-30.09.2013
   .

Institut für Mikrotechnik Mainz GmbH, Call-Zeiss-Straße 18-20, 55129 Mainz, Germany

Remote Assessibility to Diabetes Management and Therapy in Operational healthcare Networks - REACTION
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.03.2010-28.02.2014
   .

Profil Institut für Stoffwechselforschung GmbH, Hellersbergstrasse 9, 41460 Neuss, Germany

A Portable bihormonal Closed Loop for Diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Regittnig Werner
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.09.2012-31.05.2016
   .

AP@home
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.02.2010-31.10.2014
   .

Single-Port Insulin Infusion for Improved Diabetes Management
• Project type: EN: Forschungsförderung.
• Project Leader: Treiber Gerlies
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.11.2012-31.10.2017
   .

Profil Institut für Stoffwechselforschung GmbH, Germany

Clinical application for metabolic profiling
• Project type: EN: Forschungsförderung.
• Project Leader: Schaupp Lukas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.12.2010-30.04.2015
   .

Pyro Science GmbH, Germany

Single-Port Insulin Infusion for Improved Diabetes Management
• Project type: EN: Forschungsförderung.
• Project Leader: Treiber Gerlies
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.11.2012-31.10.2017
   .

Technische Universität Dresden, Germany

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

T-Systems International GmbH, Germany

Nanoelectronics for Mobile Ambient Assisted Living (AAL) Systems - Technology Platform for AAL Applications - MAS
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium Österreichische Forschungsförderungsgesellschaft mbH (FFG/mit peer review), Sensengasse 1, 1090 Wien, Austria
• Programme: EU (FP-7)
• Duration: 01.04.2010-30.09.2013
   .

Universität Ulm, Ulm, Germany

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

Universitätsklinikum Freiburg, Freiburg, Germany

Food-based solutions for Optimal vitamin D Nutrition and Health through the life cycle (ODIN)
• Project type: EN: Forschungsförderung.
• Project Leader: Pilz Stefan
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.11.2013-31.10.2017
   .

X-FAB Semiconductor Foundries AG, Germany

Nanoelectronics for Mobile Ambient Assisted Living (AAL) Systems - Technology Platform for AAL Applications - MAS
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium Österreichische Forschungsförderungsgesellschaft mbH (FFG/mit peer review), Sensengasse 1, 1090 Wien, Austria
• Programme: EU (FP-7)
• Duration: 01.04.2010-30.09.2013
   .

Foundation for Research & Technology - Hellas, 100 Nikolaou Plastira str., 100 13 Heraklion, Greece

Remote Assessibility to Diabetes Management and Therapy in Operational healthcare Networks - REACTION
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.03.2010-28.02.2014
   .

Harokopio University, Athen, Greece

Food-based solutions for Optimal vitamin D Nutrition and Health through the life cycle (ODIN)
• Project type: EN: Forschungsförderung.
• Project Leader: Pilz Stefan
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.11.2013-31.10.2017
   .

Remote Assessibility to Diabetes Management and Therapy in Operational healthcare Networks - REACTION
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.03.2010-28.02.2014
   .

ALKALMAZOTT LOGIKAI LABORATORIUM KUTATO FEJLESZTO SZOVETKEZET , Hankóczy J. u. 7., 1022 Budapest, Hungary

Remote Assessibility to Diabetes Management and Therapy in Operational healthcare Networks - REACTION
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.03.2010-28.02.2014
   .

TEHRAN UNIVERSITY OF MEDICAL SCIENCES, Teheran, Iran (Islamic Republic of)

PoC in-office device for identifying individuals at high risk of Osteoporosis and osteoporotic fracture
• Project type: EN: Forschungsförderung.
• Project Leader: Dimai Hans Peter
• MUG Research Units: Biobank Graz ; Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.10.2017-31.03.2022
   .

University College Cork, Ireland

Food-based solutions for Optimal vitamin D Nutrition and Health through the life cycle (ODIN)
• Project type: EN: Forschungsförderung.
• Project Leader: Pilz Stefan
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.11.2013-31.10.2017
   .

University College Dublin, Ireland

Food-based solutions for Optimal vitamin D Nutrition and Health through the life cycle (ODIN)
• Project type: EN: Forschungsförderung.
• Project Leader: Pilz Stefan
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.11.2013-31.10.2017
   .

DATAMED SRL, Italy

Clinical application for metabolic profiling
• Project type: EN: Forschungsförderung.
• Project Leader: Schaupp Lukas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.12.2010-30.04.2015
   .

STMicroelectronics, Via C. Olivetti 2, 20041 Agrate Brianza, Italy

AP@home
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.02.2010-31.10.2014
   .

UNIVERSITA DEGLI STUDI DI PADOVA, VIA VIII Febbraio 2, 35122 Padova, Italy

AP@home
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.02.2010-31.10.2014
   .

UNIVERSITA DEGLI STUDI DI PAVIA, Strada Nova 65, 27100 Pavia, Italy

AP@home
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.02.2010-31.10.2014
   .

Università degli Studi "G. d`Annunzio", Chieti-Pescara, Chieti, Italy

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

University of Pisa, Pisa, Italy

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

Centre Hospitalier de Luxembourg, Luxembourg

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

Single-Port Insulin Infusion for Improved Diabetes Management
• Project type: EN: Forschungsförderung.
• Project Leader: Treiber Gerlies
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.11.2012-31.10.2017
   .

Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands

A Portable bihormonal Closed Loop for Diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Regittnig Werner
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.09.2012-31.05.2016
   .

AP@home
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.02.2010-31.10.2014
   .

Academisch Ziekenhuis Leiden, Netherlands

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

Evalan BV, Netherlands

Nanoelectronics for Mobile Ambient Assisted Living (AAL) Systems - Technology Platform for AAL Applications - MAS
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium Österreichische Forschungsförderungsgesellschaft mbH (FFG/mit peer review), Sensengasse 1, 1090 Wien, Austria
• Programme: EU (FP-7)
• Duration: 01.04.2010-30.09.2013
   .

INREDA Diabetic BV, Diepenheimseweg, 7471JW Goor, Netherlands

A Portable bihormonal Closed Loop for Diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Regittnig Werner
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.09.2012-31.05.2016
   .

Katholieke Universiteit Leuven, Oude Markt 13, 3000 Leuven, Netherlands

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

Philips Consumer Lifestyle BV, Netherlands

Nanoelectronics for Mobile Ambient Assisted Living (AAL) Systems - Technology Platform for AAL Applications - MAS
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium Österreichische Forschungsförderungsgesellschaft mbH (FFG/mit peer review), Sensengasse 1, 1090 Wien, Austria
• Programme: EU (FP-7)
• Duration: 01.04.2010-30.09.2013
   .

Philips Electronics Nederland BV, Netherlands

Nanoelectronics for Mobile Ambient Assisted Living (AAL) Systems - Technology Platform for AAL Applications - MAS
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium Österreichische Forschungsförderungsgesellschaft mbH (FFG/mit peer review), Sensengasse 1, 1090 Wien, Austria
• Programme: EU (FP-7)
• Duration: 01.04.2010-30.09.2013
   .

Stichting Katholieke Universiteit - the Radboud University Nijmegen Medical Centre, Netherlands

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

Stichting Vu-Vumc, Amsterdam, Netherlands

Food-based solutions for Optimal vitamin D Nutrition and Health through the life cycle (ODIN)
• Project type: EN: Forschungsförderung.
• Project Leader: Pilz Stefan
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.11.2013-31.10.2017
   .

University of Twente, Netherlands

A Portable bihormonal Closed Loop for Diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Regittnig Werner
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.09.2012-31.05.2016
   .

GE Vingmed Ultrasound AS, Norway

Nanoelectronics for Mobile Ambient Assisted Living (AAL) Systems - Technology Platform for AAL Applications - MAS
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium Österreichische Forschungsförderungsgesellschaft mbH (FFG/mit peer review), Sensengasse 1, 1090 Wien, Austria
• Programme: EU (FP-7)
• Duration: 01.04.2010-30.09.2013
   .

Lifecare AS*LC, Norway

Nanoelectronics for Mobile Ambient Assisted Living (AAL) Systems - Technology Platform for AAL Applications - MAS
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium Österreichische Forschungsförderungsgesellschaft mbH (FFG/mit peer review), Sensengasse 1, 1090 Wien, Austria
• Programme: EU (FP-7)
• Duration: 01.04.2010-30.09.2013
   .

Stiftelsen SINTEF, Norway

Nanoelectronics for Mobile Ambient Assisted Living (AAL) Systems - Technology Platform for AAL Applications - MAS
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium Österreichische Forschungsförderungsgesellschaft mbH (FFG/mit peer review), Sensengasse 1, 1090 Wien, Austria
• Programme: EU (FP-7)
• Duration: 01.04.2010-30.09.2013
   .

Universitetet i Oslo, Oslo, Norway

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

Universitetet I Tromsoe, Norway

Food-based solutions for Optimal vitamin D Nutrition and Health through the life cycle (ODIN)
• Project type: EN: Forschungsförderung.
• Project Leader: Pilz Stefan
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.11.2013-31.10.2017
   .

Slaski Uniwersytet Medyczny w Katowicach, Katowice, Poland

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

Slovak University of Technology in Bratislava, Slovakia

Nanoelectronics for Mobile Ambient Assisted Living (AAL) Systems - Technology Platform for AAL Applications - MAS
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium Österreichische Forschungsförderungsgesellschaft mbH (FFG/mit peer review), Sensengasse 1, 1090 Wien, Austria
• Programme: EU (FP-7)
• Duration: 01.04.2010-30.09.2013
   .

Univerza v Ljubljani, Ljubljana, Slovenia

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

Acondicionamiento Tarrasense Associacion*LEITAT, Spain

Nanoelectronics for Mobile Ambient Assisted Living (AAL) Systems - Technology Platform for AAL Applications - MAS
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium Österreichische Forschungsförderungsgesellschaft mbH (FFG/mit peer review), Sensengasse 1, 1090 Wien, Austria
• Programme: EU (FP-7)
• Duration: 01.04.2010-30.09.2013
   .

Agencia Estatal Consejo Superior de Investigaciones Cientificas*CSIC, Spain

Nanoelectronics for Mobile Ambient Assisted Living (AAL) Systems - Technology Platform for AAL Applications - MAS
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium Österreichische Forschungsförderungsgesellschaft mbH (FFG/mit peer review), Sensengasse 1, 1090 Wien, Austria
• Programme: EU (FP-7)
• Duration: 01.04.2010-30.09.2013
   .

Atos Origin Sociedad Anonima Espanola, Calle Albarracín 25, 28037 Madrid, Spain

Remote Assessibility to Diabetes Management and Therapy in Operational healthcare Networks - REACTION
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.03.2010-28.02.2014
   .

Equalid Solutions S.L., Spain

Nanoelectronics for Mobile Ambient Assisted Living (AAL) Systems - Technology Platform for AAL Applications - MAS
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium Österreichische Forschungsförderungsgesellschaft mbH (FFG/mit peer review), Sensengasse 1, 1090 Wien, Austria
• Programme: EU (FP-7)
• Duration: 01.04.2010-30.09.2013
   .

Fundacion Cidetec*Centro de Tecnologias Electroquimicas, Spain

Nanoelectronics for Mobile Ambient Assisted Living (AAL) Systems - Technology Platform for AAL Applications - MAS
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium Österreichische Forschungsförderungsgesellschaft mbH (FFG/mit peer review), Sensengasse 1, 1090 Wien, Austria
• Programme: EU (FP-7)
• Duration: 01.04.2010-30.09.2013
   .

microLIQUID sl, Arrasate-Mondragon, Spain

PoC in-office device for identifying individuals at high risk of Osteoporosis and osteoporotic fracture
• Project type: EN: Forschungsförderung.
• Project Leader: Dimai Hans Peter
• MUG Research Units: Biobank Graz ; Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.10.2017-31.03.2022
   .

Universitat Rovira i Virgili, Spain

PoC in-office device for identifying individuals at high risk of Osteoporosis and osteoporotic fracture
• Project type: EN: Forschungsförderung.
• Project Leader: Dimai Hans Peter
• MUG Research Units: Biobank Graz ; Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.10.2017-31.03.2022
   .

CNet Svenska AB, Svärdvägen 3B, 182 33 Danderyd, Sweden

Remote Assessibility to Diabetes Management and Therapy in Operational healthcare Networks - REACTION
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.03.2010-28.02.2014
   .

Ecole Polytechnique Federale de Lausanne, Lausanne, Switzerland

AP@home
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.02.2010-31.10.2014
   .

SENSILE MEDICAL AG, Fabrikstrasse 10, 4614 Haegendorf, Switzerland

AP@home
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.02.2010-31.10.2014
   .

Solianis Monitoring AG, Leutschenbachstrasse 46, 8050 Zürich, Switzerland

Remote Assessibility to Diabetes Management and Therapy in Operational healthcare Networks - REACTION
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.03.2010-28.02.2014
   .

Universite de Lausanne, Lausanne, Switzerland

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

Full Yazilim Muhendislik Reklam Tanitim Turizm Organizasyon Sanayi Ticaret Limited Sirketi, Caglayan Mahallesi 2011 Sokak 5 B, 070230 Muratpasa Antalya, Turkey

A Portable bihormonal Closed Loop for Diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Regittnig Werner
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.09.2012-31.05.2016
   .

Brunel University, Kingston Lane, UB8 3PH Uxbridge, United Kingdom

Remote Assessibility to Diabetes Management and Therapy in Operational healthcare Networks - REACTION
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.03.2010-28.02.2014
   .

Chorleywood Health Centre, 15 Lower Road , WD3 5EA Chorleywood, United Kingdom

Remote Assessibility to Diabetes Management and Therapy in Operational healthcare Networks - REACTION
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.03.2010-28.02.2014
   .

Eli Lilly and Company Ltd, Lilly House Priestley Road, RG24 9NL Basingstoke, United Kingdom

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

Glaxosmithkline Research and Development LTD., Great West Road 980 Brentford, TW8 9GS Middlesex, United Kingdom

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

Kings College London, London, United Kingdom

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

Labman Automation Ltd, MIDDLESBROUGH, United Kingdom

PoC in-office device for identifying individuals at high risk of Osteoporosis and osteoporotic fracture
• Project type: EN: Forschungsförderung.
• Project Leader: Dimai Hans Peter
• MUG Research Units: Biobank Graz ; Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.10.2017-31.03.2022
   .

Medical Research Council, 2nd Floor David Phillips Building,Polaris House, North Star Avenue, SN2 1FL Swindon, United Kingdom

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

Food-based solutions for Optimal vitamin D Nutrition and Health through the life cycle (ODIN)
• Project type: EN: Forschungsförderung.
• Project Leader: Pilz Stefan
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.11.2013-31.10.2017
   .

Point 35 Microstructures Limited, United Kingdom

Nanoelectronics for Mobile Ambient Assisted Living (AAL) Systems - Technology Platform for AAL Applications - MAS
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium Österreichische Forschungsförderungsgesellschaft mbH (FFG/mit peer review), Sensengasse 1, 1090 Wien, Austria
• Programme: EU (FP-7)
• Duration: 01.04.2010-30.09.2013
   .

Probe Scientific Ltd., United Kingdom

Clinical application for metabolic profiling
• Project type: EN: Forschungsförderung.
• Project Leader: Schaupp Lukas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.12.2010-30.04.2015
   .

The Chancellor, Masters and Scholars of the University of Cambridge, Cambridge, United Kingdom

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

The Chancellor, Masters and Scholars of the University of Oxford, United Kingdom

AP@home
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.02.2010-31.10.2014
   .

The University of Manchester, United Kingdom

Food-based solutions for Optimal vitamin D Nutrition and Health through the life cycle (ODIN)
• Project type: EN: Forschungsförderung.
• Project Leader: Pilz Stefan
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.11.2013-31.10.2017
   .

TRITEQ LTD, TRITEQ LTD, Unit3 The Courtyard Stype, Hungerford, Berkshire, United Kingdom

AP@home
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.02.2010-31.10.2014
   .

University of Cambridge, Cambridge, United Kingdom

Clinical application for metabolic profiling
• Project type: EN: Forschungsförderung.
• Project Leader: Schaupp Lukas
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.12.2010-30.04.2015
   .

Single-Port Insulin Infusion for Improved Diabetes Management
• Project type: EN: Forschungsförderung.
• Project Leader: Treiber Gerlies
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.11.2012-31.10.2017
   .

University of Southhampton, United Kingdom

Food-based solutions for Optimal vitamin D Nutrition and Health through the life cycle (ODIN)
• Project type: EN: Forschungsförderung.
• Project Leader: Pilz Stefan
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.11.2013-31.10.2017
   .

University of Surrey, United Kingdom

Food-based solutions for Optimal vitamin D Nutrition and Health through the life cycle (ODIN)
• Project type: EN: Forschungsförderung.
• Project Leader: Pilz Stefan
• MUG Research Units: Division of Endocrinology and Diabetology ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.11.2013-31.10.2017
   .

JDRF International, New York, United States (USA)

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

The Leona M. and Harry B. Helmsley Charitable Trust, New York, United States (USA)

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

↑ Top of page / Navigation

© Med Uni Graz • Imprint